Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Larry G. who wrote (705)	4/28/2000 11:53:00 AM
From: Sean Janzen	Respond to of 792

Here's an interesting bit of info from MBI's prospectus dated April 6/00. "On December 16, 1999, Micrologix provided PENCE with a notice stating that the Company was terminating the PENCE Licence. Effective January 21, 2000, Micrologix, PENCE and the University of Alberta agreed to the conditions of termination of the PENCE Licence. In consideration of all outstanding funding commitments under this agreement, Micrologix agreed to continue its funding of the research collaboration to April 3, 2000. All rights to the PENCE technology revert to PENCE and Micrologix no longer has a license to exploit same." Micrologix most recent prospectus dated April 6/00 sedar.com If that link does not work then use this link: sedar.com And type in micrologix and click on the Apr 6/00 prospectus.